# MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
> **ANDA202150** · Abbreviated New Drug Application (Generic) · Sponsor: HERITAGE · Approved 2014-03-07
## Drug
- **FDA Application Number:** ANDA202150
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
- **Generic name:** Hydrochlorothiazide
- **Active ingredients:** HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HERITAGE
- **First approval:** 2014-03-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202150)
---
*AI Analytics · CC0 1.0*